Shelby L Corman (Shelby Corman)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 6

Top Venues

Future oncology (London, England)

European journal of haematology

Journal of medical economics

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Elizabeth A Szamreta, Wei-Jhih Wang, Ruchitbhai M Shah, Shelby L Corman, Matthew Monberg
The burden of ovarian cancer in the USA from 2007 to 2018: evidence from the Medical Expenditure Panel Survey. Future oncology (London, England) (2023)
José-Ángel Hernández-Rivas, Mario Arnao, José Maria Arguiñano Pérez, Araceli Rubio, Esther Gónzalez García, Dunia de Miguel, Dasha Cherepanov, Dorothy Romanus, Katharina Verleger, Courtney Johnson, Shelby L Corman, Marta Grande, Ernesto Pérez Persona
Treatment patterns and outcomes among nontransplant newly diagnosed multiple myeloma patients in Spain. Future oncology (London, England) 17 (26) (2021)
Ruchitbhai M Shah, Shelby L Corman, Anuj Shah, Nehemiah Kebede, Chizoba Nwankwo
Phase-specific and lifetime economic burden of cervical cancer and endometrial cancer in a commercially insured United States population. Journal of medical economics 24 (1) (2021)
Kevin Moore, Khurram Jamil, Katharina Verleger, Linlin Luo, Nehemiah Kebede, Marieke Heisen, Shelby L Corman, Roberta Leonardi, Rachel Bakker, Christine Maï, Nisreen Shamseddine, Xingyue Huang, Andrew S Allegretti
Real-world treatment patterns and outcomes using terlipressin in 203 patients with the hepatorenal syndrome. Alimentary pharmacology & therapeutics 52 (2) (2020)
Florent Malard, Wolfgang Knauf, Dorothy Romanus, Shelby L Corman, Katharina Verleger, Youngmin Kwon, Dasha Cherepanov, M Janelle Cambron-Mellott, Haris G Vikis, Francisco Gonzalez, Francois Gavini, Karthik Ramasamy
Real-world treatment patterns and outcomes in non-transplant newly diagnosed multiple Myeloma in France, Germany, Italy, and the United Kingdom. European journal of haematology 105 (3) (2020)
Paul J Bröckelmann, Erin A Zagadailov, Shelby L Corman, Viktor Chirikov, Courtney Johnson, Cynthia Macahilig, Brian Seal, Mehul R Dalal, Tim Illidge
Brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma who are Ineligible for autologous stem cell transplant: A Germany and United Kingdom retrospective study. European journal of haematology 99 (6) (2017)

Shelby L Corman.css-eqlu8i{font-size:small;padding-left:4px;} (Shelby Corman)

Publication Activity (10 Years)

Top Topics

Top Venues

Shelby L Corman (Shelby Corman)